Impact of steatosis on perioperative outcome following hepatic resection
- PMID: 14675713
- DOI: 10.1016/j.gassur.2003.09.012
Impact of steatosis on perioperative outcome following hepatic resection
Abstract
Fatty liver disease may interfere with liver regeneration and is postulated to result in an adverse outcome for patients subjected to partial hepatectomy. This study examines the impact of steatosis on outcome following hepatic resection for neoplasms. All patients with fatty livers (n=325) who underwent hepatectomy between December 1991 and September 2001 were identified from a prospective database. Slides were reviewed and steatosis was quantified as follows: <30% (mild) and > or =30% (marked). Patient data were gathered and compared with results in 160 control patients with normal livers; subjects were matched for age, comorbidity, and extent of liver resection. There were 223 patients with mild and 102 with marked steatosis. Those with steatosis were more likely to be men (59% marked vs. 55% mild vs. 43% control; P=0.01) with a higher body mass index (29.7+/-5.5 marked vs. 28.2+/-5.5 mild vs. 26.0+/-5.4 control; P<0.01), and treated preoperatively with chemotherapy (66% marked vs. 55% mild vs. 38% control; P<0.01). Total (62%, 48%, and 35%; P<0.01) and infective (43%, 24%, and 14%; P<0.01) complications correlated with the degree of steatosis. No difference was observed in complications requiring major medical intervention, hospitalization, or admission to the intensive care unit between groups. On multivariate analysis, steatosis was an independent predictor of complications (P<0.01, risk ratio=3.04, 95% confidence interval=1.7 to 5.54). There was a nonsignificant trend toward higher 60-day mortality in patients with marked steatosis who had lobe or more resections (9.4% marked vs. 5.0% mild vs. 5.0% control; P=0.30). Marked steatosis is an independent predictor of complications following hepatic resection but does not have a significant impact on 60-day mortality. Steatosis alone should not preclude aggressive hepatic resection for neoplasms when indicated; however, patients with marked steatosis undergoing large resections should still be approached with due caution.
Similar articles
-
Underlying steatohepatitis, but not simple hepatic steatosis, increases morbidity after liver resection: a case-control study.Hepatology. 2012 Dec;56(6):2221-30. doi: 10.1002/hep.25935. Epub 2012 Oct 14. Hepatology. 2012. PMID: 22767263
-
Hepatic steatosis as a potential risk factor for major hepatic resection.J Gastrointest Surg. 1998 May-Jun;2(3):292-8. doi: 10.1016/s1091-255x(98)80025-5. J Gastrointest Surg. 1998. PMID: 9841987
-
Hepatic steatosis, body mass index and long term outcome in patients undergoing hepatectomy for colorectal liver metastases.Eur J Surg Oncol. 2010 Jan;36(1):52-7. doi: 10.1016/j.ejso.2009.09.004. Epub 2009 Oct 29. Eur J Surg Oncol. 2010. PMID: 19879103
-
Steatosis predicts postoperative morbidity following hepatic resection for colorectal metastasis.Br J Surg. 2007 Nov;94(11):1395-402. doi: 10.1002/bjs.5820. Br J Surg. 2007. PMID: 17607707
-
Steatosis as a risk factor in liver surgery.Ann Surg. 2007 Jan;245(1):20-30. doi: 10.1097/01.sla.0000225113.88433.cf. Ann Surg. 2007. PMID: 17197961 Free PMC article. Review.
Cited by
-
Laparoscopic liver resection in obese patients.World J Surg. 2015 May;39(5):1210-5. doi: 10.1007/s00268-014-2927-y. World J Surg. 2015. PMID: 25561194
-
Severity grading of unexpected events in paediatric surgery: evaluation of five classification systems and the Comprehensive Complication Index (CCI®).BJS Open. 2021 Nov 9;5(6):zrab138. doi: 10.1093/bjsopen/zrab138. BJS Open. 2021. PMID: 35022674 Free PMC article.
-
Liver resection for advanced or aggressive colorectal cancer metastases in the era of effective chemotherapy: a review.Int J Clin Oncol. 2011 Oct;16(5):452-63. doi: 10.1007/s10147-011-0291-6. Epub 2011 Jul 26. Int J Clin Oncol. 2011. PMID: 21786210 Review.
-
Liver injury induced by anticancer chemotherapy and radiation therapy.Int J Hepatol. 2013;2013:815105. doi: 10.1155/2013/815105. Epub 2013 Jul 17. Int J Hepatol. 2013. PMID: 23970972 Free PMC article.
-
Computational Modeling in Liver Surgery.Front Physiol. 2017 Nov 14;8:906. doi: 10.3389/fphys.2017.00906. eCollection 2017. Front Physiol. 2017. PMID: 29249974 Free PMC article. Review.
References
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical